Mark Asset Management’s Inhibrx INBX Stock Holding History

Mark Asset Management’s Portfolio INBX Stock Details INBX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-17,000	Closed	-$243K	–	57
2025 Q2	$243K	Buy	+17,000	New	+$220K	0.02%	52

Other funds holding INBX

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Sanofi Paris, France $336M AUM 126.85% 1-Year Est. Return

HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return

Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Mark Asset Management's INBX Position: Q3 2025 in Review

Mark Asset Management sold out of Inhibrx (INBX) in Q3 2025, closing a stake of 17,000 shares — an estimated $243K sold.

Mark Asset Management first reported a position in INBX in Q2 2025 and held it in 1 quarter. The position peaked at $243K in Q2 2025. 102 funds tracked by Wall St. Rank hold INBX as of Q3 2025.

Mark Asset Management reported no remaining Inhibrx position as of Q3 2025 after selling out during the quarter.
Mark Asset Management sold 17,000 Inhibrx shares in Q3 2025, an estimated $243K.
Mark Asset Management first reported a position in Inhibrx in Q2 2025 and held it in 1 quarter.
Mark Asset Management's Inhibrx position peaked at $243K in Q2 2025.
102 funds tracked by Wall St. Rank held Inhibrx as of Q3 2025.

Based on Mark Asset Management's 13F filing for Q3 2025, filed 14 Nov 2025.